Behind the MR‑Linac Consortium's progress is a group dedicated to advancing what’s possible in cancer care. The Clinical Steering Committee drives research focus, quality excellence, and global collaboration—fueling the rapid expansion of MR‑guided radiotherapy and improving outcomes for patients.

Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.

Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.

Abstract submissions for the MR‑Linac Consortium Meeting 2026 are now open! We welcome your research and insights as we prepare for an exciting gathering in Montreal. Submit your abstract today via the link in your emails or on the member portal. lnkd.in/ef3TrgGS #ProgressThroughCollaboration

Ready to spotlight your expertise in MR-guided Radiotherapy (MRgRT)? We’re looking for standout content: creative media, inspiring clinical cases, and innovative approaches that highlight the real impact of MRgRT in transforming treatment. 💡 Submit your entry today! lnkd.in/e3cc6-2k

Radiographer-led adaptive #MRgRT workflows are reshaping radiotherapy, streamlining processes, and improving patient experience. Hear Charlie Tran from GenesisCare Australia : lnkd.in/erTKBt6C #ProgressThroughCollaboration mrlconsortium.org

Celebrating Global Collaboration in MR-Linac Research! The MR-Linac Consortium continues to thrive as a truly international community, united by a shared mission to advance precision radiation therapy. Don’t miss this conversation with Dr. Qian Peng, Radiation Oncologist in China: lnkd.in/eve3usMq

At the 20th Consortium meeting, it was inspiring to connect with so many members and see the progress being made in MRgRT. We're grateful to all who contributed their expertise and enthusiasm. Until next time!

We are thrilled that Rad Chat joined us at the MR-Linac Consortium meeting! Rad Chat is a multi award winning podcast, education and social media platform focusing on radiotherapy and oncology. Curious to hear what Consortium attendees shared with them. Listen here: radchat.transistor.fm/episodes

Today we awarded the best clinical, technical and young investigator abstracts. Congrats to this year's winners: Julia Peltenburg and Marlies Nowee, Xiangyu Zhang and Tariq Lalmahomed for their work in motion management, prostate cancer QoL and liver oligometastases treatment.

The MR-Linac Consortium meeting kicked off today with 300+ members focused on sharing clinical data, research and the future of MRgRT. Huge thanks to our 2025 Organization Committee and Clinical Steering Committee Chair, Dr. Alison Tree, for driving MR-adaptive forward.

📄 This MOMENTUM study highlights the safety and tolerability of MRI-guided SBRT for liver metastases, showing promising results in maintaining disease control with manageable side effects. Patients reported a stable quality of life throughout treatment. lnkd.in/eN8sEzmz #MOMENTUM #LiverCancer

www.mrlconsortium.org #ProgressThroughCollaboration

Research from UTSW explores how PSMA-PET imaging can guide adaptive SABR in high-risk prostate cancer—refining tumor boosts based on response, without adding treatment time. MR-Linac and CBCT systems can offer practical paths to personalized, biology-driven radiotherapy. lnkd.in/e4pHnZg2

We’re thrilled to announce that the speaker lineup for the MR-Linac Consortium Meeting this November is confirmed! Last year’s meeting brought together brilliant minds, bold ideas, and transformative conversations in MR-guided radiotherapy and this year promises to be even more impactful.

This study explores the feasibility and early outcomes of MR-guided stereotactic ablative radiotherapy (MRgSTAR) for patients with synchronous oligometastatic prostate cancer (OMPC). ✅ 100% 3-year overall survival ✅ 95.2% progression-free survival www.frontiersin.org/journals/onc...

This retrospective analysis of five patients treated in the MOMENTUM study highlights that daily MR-adaptation reduces dose variability and OAR exposure compared to MR-guided plans alone for cervical cancer. #CervicalCancer #MOMENTUM medicaljournalssweden.se/actaoncologi...

🚨A recent study leveraging MOMENTUM’s extensive dataset underlines that online adaptive MR-guided radiotherapy (MRgRT) shows promise for patients with non-metastatic pancreatic cancer. ✅ Maintained quality of life ✅ Significant symptom improvement at 6 months www.redjournal.org/article/S036...

Advancing MR-Guided Radiotherapy in Esophageal Cancer A recent study from UMC Utrecht, explores the ATS-lite workflow—a simplified approach to online adaptive MRgRT which streamlines treatment delivery to a median of 23 minutes, while maintaining 90% target coverage.

Researchers in Nijmegen, Netherlands, have created an open-access online tool for early economic evaluation. This tool provides insights into the cost-effectiveness of MRIgRT. lnkd.in/e2sRxFRs Users can input their own data lnkd.in/erDkxXpF www.mrlconsortium.org hashtag#ProgressThroughCollaboration

www.mrlconsortium.org #ProgressThroughCollaboration

Excited to see the MARS trial highlighted here @cihangani.bsky.social @elekta.com @mrlconsortium.bsky.social @momentumstudy.bsky.social

🗓️Is it time to retire the PTV concept? In this article, members of the MR-Linac Consortium in the Netherlands discuss advancements in online adaptive radiation therapy (RT) and its implications for planning target volume margins. 📊 www.redjournal.org/article/S036...

This study from Brescia compared Elekta Unity with Accuray Radixact outcomes for oropharyngeal cancer treatment. It shows that daily ATS workflow for treatment is feasible and well-tolerated, with potential advantages compared to helical tomotherapy. www.ctro.science/article/S240...

🔬 Transforming Cancer Care 💡 Explore how we're shaping the future of cancer care through: ✔️ Cutting-edge clinical research ✔️ A community dedicated to advancing patient outcomes ✔️ A global network of experts and institutions 🌐 Learn more at www.mrlconsortium.org #ProgressThroughCollaboration

#ProgressThroughCollaboration www.mrlconsortium.org

#ProgressThroughCollaboration www.mrlconsortium.org

The HERMES trial from RMH London studied two MRI-guided adaptive prostate radiotherapy regimens. Both 5 and 2 fraction treatments are feasible with encouraging toxicity outcomes. www.redjournal.org/article/S036... @prostatecanceruk.bsky.social

#ProgressThroughCollaboration www.mrlconsortium.org

Sun Yat-sen University Cancer Centre report promising results for online hypo-fractionated adaptive MRgRT in treating brain metastases in non-small cell lung cancer. www.thelancet.com/journals/ecl... # progressthroughcollaboration @braintumourrsch.bsky.social @braintumourcharity.bsky.social

This recent study from University of Iowa Health Care, describes the treatment strategies for 8 patients with central lung tumors using Comprehensive Motion Management on a 1.5T MR-Linac. www.frontiersin.org/journals/onc... @lungevity.bsky.social

Some prostate patients experience urinary urgency during their radiation treatment. ​ That pressure can cause the prostate to move inferiorly, highlighted here in the video below courtesy of Dr Cem Onal, University of Başkent #ProgressThroughCollaboration

Members of the Chinese MR Linac Consortium group recently published two interesting articles on treatment of large brain metastases and cardiac sarcoma using MRgRT. www.redjournal.org/article/S036... www.thegreenjournal.com/article/S016... #ProgressThroughCollaboration

The team at IOWA successfully commissioned the real-time target tracking and beam control system for the 1.5 T Elekta MR-Linac. aapm.onlinelibrary.wiley.com/doi/10.1002/... #Progressthroughcollaboration #mrlconsortium

See and manage small bowel position changes with online adaptive MR-guided workflows! www.mrlconsortium.org

Don't miss out on our next webinar! Everything you need to know to get started on scripting in Monaco with guest speaker Alex Solodkin. www.mrlconsortium.org

With this study, Pim Borman won the Young Investigator award at the Consortium Meeting. This work nicely demonstrated the MR-Linac’s capability to handle VMAT and MLC tracking at the same time. www.phiro.science/article/S240...

Dr. Alborz Jooya, a Radiation Oncologist at Alberta Health Services in Calgary, recently presented groundbreaking patient-reported quality of life findings at the MRL Consortium in Singapore, November 2024. #Healthcare #Oncology #PatientCare #QualityOfLife #MedicalResearch

An international survey of 23 sites shows T2W MRI is preferred for urethra contouring to reduce urinary toxicity in prostate cancer patients undergoing EBRT. doi.org/10.1016/j.ct... @prostatecanceruk.bsky.social @prostatecancerguy.bsky.social

Don't miss out on our first webinar of 2025! Open to all MR-Linac Consortium members. Member Portal Access: www.mrlconsorium.org

This article, utilizing data from MOMENTUM, demonstrates that MR-guided SBRT for pancreatic oligometastases from RCC is a promising, safe, and effective treatment. It may delay systemic therapy, providing high local control and low toxicity. doi.org/10.1016/j.ph... @kidneycancer.bsky.social

🔍 The Radiation Therapist (RTT) Brainstorm Group met during the annual MRL Consortium meeting in Singapore, Nov 2024. One of the topics of discussion was future opportunities for RTT role expansion. The word cloud shows key areas highlighted for consideration. 🔍 www.mrlconsortium.org

🌟New Focus Article Alert 🌟Elekta’s latest Focus article showcases the outstanding contributions of the MRL Consortium members and provides an update on the recent meeting held in Singapore. Read article here: www.elekta.com/focus/mr-lin... #Elekta #MRLConsortium #HealthcareInnovation #MRgRT

With this study, Maximilian Konrad won the Technical Abstract award at the Consortium Meeting. He investigated the feasibility and time gain of implementing a home-made online AI-based contouring solution on Unity. www.phiro.science/article/S240... @prostatecanceruk.bsky.social

Don't miss out on our first webinar of 2025! Open to all MR-Linac Consortium members. www.mrlconsorium.org

Sim-free MRgRT was a hot topic at the recent MR-Linac Consortium. This article and several other abstracts were discussed at a dedicated sim-free session. Simulation-free magnetic resonance-guided radiation therapy of prostate cancer - Physics and Imaging in Radiation Oncology lnkd.in/emApGyW6

Don't miss out on the latest in MRgRT! Join our webinar to hear insights from the MR-Linac Consortium Meeting. Topics include: 🔹Clinical updates 🔹Workflow efficiencies: sim-free&RTT-led 🔹Future advancements in AI & biomarker imaging. Register now! bit.ly/49ktL73 #MRgRT